Serum Metabolomics study of Patients with Allergic Rhinitis.
Allergic rhinitis (AR)has negative effects in many people's healthy lives. Most of the previous studies were focused on the expression of cytokines, and few studies were analyzed from the perspective of metabolomics. Therefore, it is worthy to conduct researches on allergic rhinitis at the metabolic level. The purpose of this study was to identify differential serum biomarkers by metabolomics. In this study, the OPLS-DA model was applied to characterize the differences of the serum samples between AR patients and healthy volunteers. A total of 10 metabolites (except hexadecanoic acid) have been found to alter significantly (p < 0.05) by the principal component analysis (PCA) and orthogonal partial least squares discriminant analysis (OPLS-DA), which could be the potential biomarkers. MetaboAnalyst 4.0 and pathway enrichment analysis showed that these metabolite changes mainly involved three pathways: porphyrin and chlorophyll metabolism, arachidonic acid metabolism and purine metabolism. These findings may contribute to a better understanding of the potential pathogenesis mechanisms and provides a metabolic evidence for deeper study of AR.